📢#ASCO2024@BlancJeremy presented survival data from AURA trial: Avelumab as neoadjuvant therapy in patients with muscle-invasive urothelial carcinoma at ASCO2024 in Chicago,USA🇺🇸
🫱🏻🫲🏽Many thanks to all those who contributed to this trial.
At the @oncodistinct meeting @Lucarecco, Research Fellow at @JulesBordet, presents #BrainStorm, investigator-initiated study focusing on patients with brain metastases🧠 sponsored by @JulesBordet 🇧🇪and recruiting in 🇧🇪🇳🇱🇫🇷
Important study addressing a huge unmet need!
@OncoAlert
🆕🔊 First patient was recruited into the COPERNIC trial! A study from the OncoDistinct Network, aiming to evaluate the association between early changes of ctDNA and response to treatment in patients with advanced colorectal cancer. 🙌
#ColorectalCancer#ClinicalTrials#oncology
OncoDistinct Team was at #ESMO2023 🇪🇦
○ Professor Ahmad Awada, one of the creators of this Network
○ Nuria Kotecki, executive officer of the OncoDistinct Network
○ Jacques Medioni, active member of the Network
○ Sofiane Bendiab, project coordinator of the OncoDistinct Network
Brain metastases are still one of the biggest challenges in oncology
#BrainStorm is an international platform that gathers clinical, imaging & molecular data to inform better management strategies
Check it out on @NatureMedicine
👉 https://t.co/3uQCGK1qoI
@OncoAlert#bcsm
📍#BrainStorm (NCT04109131), an investigator-initiated prospective #ClinicalStudy recruiting in 🇧🇪🇫🇷🇱🇺 to better understand #epidemio & #biology of 🧠 metastases
🗞 Hot off the press our correspondence to @NatureMedicine explaining design&objectives
👉https://t.co/yO5Rq4ZfIa 🧵
#BrainStorm Investigator Meeting: building a research platform to better understand and face the challenge of 🧠 metastases
A great collaboration 🇧🇪🇫🇷🇱🇺 with a key contribution from @OncoDNA in #liquidbiopsy#NGS 🧬
More info 👉https://t.co/yfhwZdJoub
@nuriakb@oncodistinct
🔎 L’IPC à la pointe de l’innovation thérapeutique en oncologie : Ouverture d’une étude de première administration à l’homme d’une thérapie innovante en partenariat avec @InnatePharma et le réseau @oncodistinct
👉 Lire le communiqué de presse https://t.co/HdDzZxjJ14